CXCL8 and colorectal cancer: EGCG inhibited the microenvironment-induced angiogenesis of colorectal cancer through the Janus kinase/signal transducer and activator of transcription 3/interleukin-8 (JAK/STAT3/IL-8) pathway and inhibited the invasion and metastasis of colorectal cancer [89].